AME
VC Fund
Santiago, Chile
AME is a Chilean energy generating company.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries AME invests in
Stages AME invests in
Countries AME invests in
Investment Focus
Industry
- Fuel 1 (33%)
- Energy 1 (33%)
- Robotics 1 (33%)
- Software 1 (33%)
- Biotechnology 1 (33%)
Stage
- Series B 1 (33%)
- Private Equity 1 (33%)
- Corporate Round 1 (33%)
Country
- Chile 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HIF Global
|
HIF Global is an eFuel company engaged in the production of carbon-neutral fuels. The company uses renewable energy to produce green hydrogen via electrolysis and captures CO2 from the atmosphere, or from an industrial or biogenic source. It produces a carbon-neutral equivalent of liquefied petroleum gas (LPG) with green methanol. HIF Global'smission is to accelerate decarbonization by producing carbon neutral eFuels, providing a solution today for a better tomorrow. | $164M / Corporate Round / May 13, 2024 | |
|
HIF Global
|
HIF Global is an eFuel company engaged in the production of carbon-neutral fuels. The company uses renewable energy to produce green hydrogen via electrolysis and captures CO2 from the atmosphere, or from an industrial or biogenic source. It produces a carbon-neutral equivalent of liquefied petroleum gas (LPG) with green methanol. HIF Global'smission is to accelerate decarbonization by producing carbon neutral eFuels, providing a solution today for a better tomorrow. | $260M / Private Equity / Apr 06, 2022 | |
Strateos
|
Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficientlydiscover new drug candidates.Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development.By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money.Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology.Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs.They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists. | $56.1M / Series B / Jun 08, 2021 |
Co-Investors
Baker Hughes
2 deals together
DCVC
2 deals together
EIG Global Energy Partners(EIG)
2 deals together
Porsche
2 deals together
Ally Bridge Group
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does AME invest in?
AME invests primarily in Fuel, Energy and Robotics startups, most often at Series B and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in Chile. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did AME last invest?
The most recent investment recorded for AME closed in May 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
